𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations

✍ Scribed by T. Krings; S.M. Chng; A. Ozanne; H. Alvarez; G. Rodesch; P.L. Lasjaunias

Publisher
Springer
Year
2005
Tongue
English
Weight
406 KB
Volume
47
Category
Article
ISSN
0028-3940

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bevacizumab to treat complicated liver v
Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: A word of caution
✍ Elisabetta Buscarini; Guido Manfredi; Alessandro Zambelli πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 45 KB

We read with interest the article by Mitchell et al. 1 dealing with bevacizumab treatment of a patient with hereditary hemorrhagic telangiectasia (HHT), cardiac failure, and portal hypertension due to severe liver vascular malformations (VMs). The treatment reversed the need for liver transplantatio

The effect of bevacizumab (Avastin) trea
The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia
✍ Jana Simonds; Frank Miller; Jess Mandel; Terence M. Davidson πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

## Abstract ## Objectives/Hypothesis: Determine the effectiveness of treating epistaxis in hereditary hemorrhagic telangiectasia (HHT) with potassium titanyl phosphate (KTP) laser cautery combined with submucosal injection of 100 mg of bevacizumab. ## Study Design: Retrospective pilot study. ##